Accessing GLP-1 treatment in Cupertino, California has traditionally meant longer waits than mainland patients face. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Cupertino address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Cupertino is already seeing results
Wegovy in Cupertino, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in Cupertino from $199/month with virtual consultations and direct-to-door shipping.
For many people in Cupertino, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved in 2021 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Cupertino.
Research suggests Semaglutide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In Cupertino, Weight Method pairs compounded Semaglutide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.